 |
市場調查報告書
商品編碼
2008073
兒童抗生素市場：按感染疾病、給藥途徑、分銷管道和地區分類Pediatric Antibiotics Market, By Infection, By Route Of Administration, By Distribution Channel, By Geography |
||||||
價格
簡介目錄
2026年，兒童抗生素市場規模估計為68億美元，預計2033年將達到92億美元。預計2026年至2033年，該市場將以3.1%的複合年成長率成長。
| 分析範圍 | 分析詳情 | ||
|---|---|---|---|
| 基準年 | 2025 | 市場規模（2026 年） | 68億美元 |
| 效能數據 | 2020-2024 | 預測期 | 2026-2033 |
| 預測期（2026-2033 年）複合年成長率 | 3.10% | 預計金額（2033 年） | 92億美元 |
抗生素用於治療或預防某些類型的細菌感染疾病。它們透過殺死細菌或抑制細菌的生長和擴散來發揮作用。抗生素是兒童最常使用的處方藥，能夠挽救嚴重細菌感染疾病（例如非特異性上呼吸道感染疾病和尿道感染）患者的生命。抗生素口服，劑型包括錠劑、液體懸浮液和膠囊。它們也可以靜脈注射。外用藥物有軟膏、乳霜和洗劑等劑型。
市場動態
全球領先的兒童抗生素主要企業正致力於採取產品核可等成長策略，預計將推動預測期內的市場成長。例如，2020年1月，全球領先的生物製藥公司默克（在美國和加拿大以外地區稱為MSD）宣布，美國食品藥物管理局（FDA）已批准其兒童懸浮液“DIFICID（非達黴素）”的新藥認證申請（NDA）及其片劑“DIFICID”的補充新藥認證申請（sADCD），核准治療兒童也將推動預測期內的市場成長。例如，2021年，聯合國兒童基金會在54個國家向1歲以下嬰兒提供了3,160萬劑抗生素。
本報告的主要特點
- 本報告對全球兒童抗生素市場進行了詳細分析，包括市場規模和預測期（2022-2030 年）的複合年成長率，以 2021 年為基準年。
- 此外，它還確定了每個細分市場的潛在商機，並描述了該市場中一系列有吸引力的投資提案。
- 此外，它還提供了有關市場促進因素和限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要企業採取的競爭策略的重要見解。
- 本文根據以下參數，介紹了全球兒童抗生素市場主要企業的概況：公司概況、產品系列、主要亮點、財務表現和策略。
- 《全球兒童抗生素市場》報告面向該行業的各種相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
- 相關人員可以透過分析全球兒童抗生素市場中使用的各種策略矩陣來促進決策。
目錄
第1章：分析目標與假設
- 分析目的
- 先決條件
- 簡稱
第2章 市場展望
- 報告說明
- 市場定義和範圍
- 執行摘要
- Coherent Opportunity Map（COM）
第3章：市場動態、監管與趨勢分析
- 市場動態
- 促進因素
- 阻礙因素
- 機會
- 影響分析
- 法規環境
- 市場趨勢
- 主要進展
- 流行病學
- PEST分析
- 商業合作與企業併購
- 波特五力分析
- 治療流程
第4章：全球兒童抗生素市場：依感染疾病分類（2026-2033 年）
- 急性鼻竇炎
- 急性中耳炎
- 非特異性上呼吸道感染疾病
- 尿道感染
- 其他
第5章：全球兒童抗生素市場：依給藥途徑分類（2026-2033 年）
- 口服
- 外用
- 靜脈
- 其他
第6章：全球兒童抗生素市場：依分銷管道分類（2026-2033 年）
- 醫院藥房
- 零售藥房
- 電子商務
第7章 全球兒童抗生素市場：按地區分類（2026-2033 年）
- 北美洲
- 美國
- 加拿大
- 拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲
- 歐洲
- 英國
- 德國
- 法國
- 義大利
- 西班牙
- 俄羅斯
- 其他歐洲國家
- 亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太地區
- 中東
- GCC
- 以色列
- 其他中東國家
- 非洲
- 北非
- 中非
- 南非
第8章 競爭情勢
- 熱圖分析
- 市佔率分析
- Johnson &Johnson
- Astellas Pharma, Inc.
- Pfizer Inc.,
- Novartis AG
- Bayer AG
- Bristol-Myers Squibb Company
- Abbott
- DAIICHI SANKYO COMPANY, LIMITED
- Reddy's Laboratories Ltd
- Teva Pharmaceuticals USA, Inc.
- Aurobindo Pharma USA
- GlaxoSmithKline Plc.,
- Hikma Pharmaceuticals PLC
- Cipla Inc.
- Glenmark Pharmaceuticals
- Torrent Pharmaceuticals Ltd.
第9章
- 分析方法
- 關於 Coherent Market Insights
簡介目錄
Product Code: CMI5190
Pediatric Antibiotics Market is estimated to be valued at USD 6.8 Bn in 2026 and is expected to reach USD 9.2 Bn by 2033, growing at a compound annual growth rate (CAGR) of 3.1% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 6.8 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 3.10% | 2033 Value Projection: | USD 9.2 Bn |
Antibiotics are used to treat or prevent some types of bacterial infection. Antibiotics work by killing bacteria or preventing them from reproducing and spreading. Antibiotics are the most commonly prescribed drugs in children and have the potential to save the lives of patients with severe bacterial infections such as Non-Specific Upper Respiratory Tract Infections, Urinary Tract Infections etc. They are taken orally and come in the form of tablets, liquid suspension, and capsules. Antibiotics are also administered through the intravenous route. Antibiotics are available in the form of ointments, creams, lotions, etc. for topical administration.
Market Dynamics
Key players operating in the global pediatric antibiotics market are focusing on adoption of growth strategies such as product approval, which is expected to drive market growth during the forecast period. For instance, in January 2020, Merck a leading global biopharmaceutical company known as MSD outside of the U.S. and Canada, announced that the U.S. Food and Drug Administration (FDA) had approved a New Drug Application (NDA) for DIFICID (fidaxomicin) for oral suspension, and a supplemental New Drug Application (sNDA) for DIFICID tablets for the treatment of Clostridioides (formerly Clostridium) difficile-associated diarrhea (CDAD) in children aged six months and older. Moreover, increasing demand of pediatric antibiotics is expected to propel market growth over the forecast period. For instance, in 2021, United Nations International Children's Emergency Fund (UNICEF) delivered 31.6 million antibiotic treatments to children under one year of age in 54 countries.
Key features of the study
- This report provides in-depth analysis of the global pediatric antibiotics market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global pediatric antibiotics market based on the following parameters - Company Highlights, Products Portfolio, Key Highlights, Financial Performance, Strategies
- Key companies covered as a part of this study include Johnson & Johnson, Astellas Pharma, Inc, Pfizer Inc., Novartis AG, Bayer AG, Bristol-Myers Squibb Company, Abbott., DAIICHI SANKYO COMPANY, LIMITED, Dr. Reddy's Laboratories Ltd, Teva Pharmaceuticals USA, Inc., Aurobindo Pharma USA, GlaxoSmithKline Plc., Hikma Pharmaceuticals PLC, Cipla Inc., Glenmark Pharmaceuticals, and Torrent Pharmaceuticals Ltd. Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global pediatric antibiotics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pediatric antibiotics market.
Market Segmentation
- By Infection
- Acute Sinusitis
- Acute Otitis Media
- Non-Specific Upper Respiratory Tract Infections
- Urinary Tract Infections and Others
- By Route Of Administration
- Oral
- Topical
- Intravenous
- Others
- By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- E-Commerce
- By Regional Insights
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Johnson & Johnson
- Astellas Pharma, Inc
- Pfizer Inc.
- Novartis AG
- Bayer AG
- Bristol-Myers Squibb Company
- DAIICHI SANKYO COMPANY, LIMITED
- Reddy's Laboratories Ltd
- Teva Pharmaceuticals USA, Inc.
- Aurobindo Pharma USA
- GlaxoSmithKline Plc.
- Hikma Pharmaceuticals PLC
- Cipla Inc.
- Glenmark Pharmaceuticals
- Torrent Pharmaceuticals Ltd.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Infection
- Market Snapshot, By Route Of Administration
- Market Snapshot, By Distribution Channels
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunity
- Impact Analysis
- Regulatory Scenario
- Market Trends
- Key Developments
- Epidemiology
- PEST Analysis
- Collaboration and Acquisition
- Porters Analysis
- Treatment Algorithm
4. Global Pediatric Antibiotics Market, By Infection, 2026-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021-2033
- Segment Trends
- Acute Sinusitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033,(USD Bn)
- Acute Otitis Media
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033,(USD Bn)
- Non-Specific Upper Respiratory Tract Infections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033,(USD Bn)
- Urinary Tract Infections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033,(USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033,(USD Bn)
5. Global Pediatric Antibiotics Market, By Route of Administration, 2026-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021-2033
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033,(USD Bn)
- Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033,(USD Bn)
- Intravenous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033,(USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033,(USD Bn)
6. Global Pediatric Antibiotics Market, By Distribution Channel, 2026-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021-2033
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033,(USD Bn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033,(USD Bn)
- E-Commerce
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033,(USD Bn)
7. Global Pediatric Antibiotics Market, By Region, 2026-2033, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2021-2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Infection, 2026 -2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2026-2033, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Infection, 2026 -2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2026-2033, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Infection, 2026 -2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2026-2033, (USD Bn)
- U.K.
- Germany
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Infection, 2026 -2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2026-2033, (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Infection, 2026 -2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2026-2033, (USD Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Infection, 2026 -2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2026-2033, (USD Bn)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
- Johnson & Johnson
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Astellas Pharma, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Pfizer Inc.,
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Novartis AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Bayer AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Bristol-Myers Squibb Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Abbott
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- DAIICHI SANKYO COMPANY, LIMITED
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Reddy's Laboratories Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Teva Pharmaceuticals USA, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Aurobindo Pharma USA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- GlaxoSmithKline Plc.,
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Hikma Pharmaceuticals PLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Cipla Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Glenmark Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Torrent Pharmaceuticals Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Johnson & Johnson
9. Section
- Research Methodology
- About us
